These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 23542579)

  • 1. Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients.
    Chung YW; Bae HS; Song JY; Lee JK; Lee NW; Kim T; Lee KW
    Int J Gynecol Cancer; 2013 May; 23(4):673-9. PubMed ID: 23542579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNA expression profiles in ovarian cancer.
    Ayaz L; Çayan F; Balci Ş; Görür A; Akbayir S; Yıldırım Yaroğlu H; Doğruer Unal N; Tamer L
    J Obstet Gynaecol; 2014 Oct; 34(7):620-4. PubMed ID: 24911418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
    Ruan L; Xie Y; Liu F; Chen X
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():31-38. PubMed ID: 29353130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel serum microRNA panel to discriminate benign from malignant ovarian disease.
    Langhe R; Norris L; Saadeh FA; Blackshields G; Varley R; Harrison A; Gleeson N; Spillane C; Martin C; O'Donnell DM; D'Arcy T; O'Leary J; O'Toole S
    Cancer Lett; 2015 Jan; 356(2 Pt B):628-36. PubMed ID: 25451316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer.
    Kan CW; Hahn MA; Gard GB; Maidens J; Huh JY; Marsh DJ; Howell VM
    BMC Cancer; 2012 Dec; 12():627. PubMed ID: 23272653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.
    Suryawanshi S; Vlad AM; Lin HM; Mantia-Smaldone G; Laskey R; Lee M; Lin Y; Donnellan N; Klein-Patel M; Lee T; Mansuria S; Elishaev E; Budiu R; Edwards RP; Huang X
    Clin Cancer Res; 2013 Mar; 19(5):1213-24. PubMed ID: 23362326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes virus microRNA expression and significance in serous ovarian cancer.
    Pandya D; Mariani M; McHugh M; Andreoli M; Sieber S; He S; Dowell-Martino C; Fiedler P; Scambia G; Ferlini C
    PLoS One; 2014; 9(12):e114750. PubMed ID: 25485872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.
    Zhu T; Gao W; Chen X; Zhang Y; Wu M; Zhang P; Wang S
    Int J Gynecol Cancer; 2017 Jan; 27(1):3-10. PubMed ID: 27636713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential microRNA expression by Solexa sequencing in the sera of ovarian cancer patients.
    Ji T; Zheng ZG; Wang FM; Xu LJ; Li LF; Cheng QH; Guo JF; Ding XF
    Asian Pac J Cancer Prev; 2014; 15(4):1739-43. PubMed ID: 24641401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.
    Resnick KE; Alder H; Hagan JP; Richardson DL; Croce CM; Cohn DE
    Gynecol Oncol; 2009 Jan; 112(1):55-9. PubMed ID: 18954897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.
    van Schooneveld E; Wouters MC; Van der Auwera I; Peeters DJ; Wildiers H; Van Dam PA; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
    Breast Cancer Res; 2012 Feb; 14(1):R34. PubMed ID: 22353773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
    Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
    Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer.
    Záveský L; Jandáková E; Weinberger V; Minář L; Hanzíková V; Dušková D; Drábková LZ; Svobodová I; Hořínek A
    Reprod Sci; 2019 Apr; 26(4):510-522. PubMed ID: 29779470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types.
    Kobayashi M; Sawada K; Nakamura K; Yoshimura A; Miyamoto M; Shimizu A; Ishida K; Nakatsuka E; Kodama M; Hashimoto K; Mabuchi S; Kimura T
    J Ovarian Res; 2018 Sep; 11(1):81. PubMed ID: 30219071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma.
    Yu X; Zhang X; Bi T; Ding Y; Zhao J; Wang C; Jia T; Han D; Guo G; Wang B; Jiang J; Cui S
    Tumour Biol; 2013 Dec; 34(6):3501-8. PubMed ID: 23836287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
    Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
    Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.